Pull to refresh
Logo
FTC and states settle pesticide antitrust case against Corteva

FTC and states settle pesticide antitrust case against Corteva

Rule Changes

Four-year antitrust settlement bans post-patent loyalty programs; Syngenta case continues

Today: Stipulated order filed

Overview

Updated 1 hour ago

American farmers paid elevated prices for crop protection because the two biggest pesticide makers paid distributors to block cheaper generic rivals. That's the theory behind a four-year antitrust case the Federal Trade Commission and 12 states brought. On September 28, it closed against Corteva.

Corteva agreed to a 10-year order requiring it to dismantle its loyalty programs and to pay $35 million. The same allegations still stand against Syngenta, whose case continues.

Why it matters

If Syngenta settles too, generic pesticide competition reaches US distributors, and farmers stop paying monopoly prices on post-patent crop protection.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$35M
Payment to state plaintiffs
Corteva pays the 12 plaintiff states to resolve their monetary claims.
12
States in plaintiff coalition
California, Colorado, Illinois, Indiana, Iowa, Minnesota, Nebraska, Oregon, Tennessee, Texas, Washington and Wisconsin.
10 years
Length of injunction
The stipulated order prohibits Corteva's exclusionary loyalty programs for a decade.
50%
Prohibited share threshold
Corteva can no longer condition payments on a distributor buying more than half its needs from the company.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

September 2022 September 2026

8 events Latest: Today
Tap a bar to jump to that date
  1. Stipulated order filed

    Today Settlement

    Corteva to pay $35M, end loyalty programs for 10 years; FTC announces settlement.

Scenarios

1

Syngenta Settles on Parallel Terms

Likely Resolves by Q3 2027

Discussed by: Law360, MLex and the FTC press release note the Syngenta case continues; analysts expect settlement to follow Corteva's precedent

With Corteva resolved, the same theory and the same distribution-channel evidence now face Syngenta. A settlement would likely mirror the Corteva order: end loyalty programs, stop tying rebates to purchase share, and pay state claims. The FTC's stated goal of restoring competition would be met without a trial.

2

Syngenta Case Goes to a Merits Ruling

Possible Resolves by Q2 2029

Discussed by: Court filings show both defendants' summary judgment motions already briefed before the stay

If no settlement arrives, litigation resumes. Both sides filed summary judgment motions in early 2026, so the case is positioned for a court decision on whether loyalty programs that exclude generic rivals violate antitrust law. A ruling would set precedent beyond these two companies.

3

Generic Competition Cuts Farmer Prices

Uncertain Resolves by End of 2029

Discussed by: The FTC press release frames the settlement as lowering pesticide prices; market analysts expect generic producers like ADAMA to gain distribution access

The deal's core promise is that removing loyalty programs lets cheaper generic pesticides reach distributors. If that holds, farmers pay less for post-patent crop protection. The effect is measurable in price data, though distribution shifts and retail margins could dampen it.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

December 2009 – August 2010

FTC v. Intel (2009-2010)

The FTC sued Intel for giving computer makers rebates tied to buying most of their chips from Intel, and for punishing makers that used AMD. Intel's payments kept AMD's competing chips out of key machines.

Then

Intel settled in August 2010, agreeing to stop the conditional rebates and to pay the states involved.

Now

The case marked a federal enforcement win against exclusive loyalty rebates that blocked a rival, cementing the theory that such payments can be illegal exclusion.

Why this matters now

Corteva's loyalty program used the same mechanism: end-of-year payments conditioned on buying almost all requirements from the incumbent, squeezing out generic rivals.

June 2013

FTC v. Actavis / pay-for-delay (2013)

In a Supreme Court case, the FTC challenged settlements where brand-name drugmakers paid generic competitors to delay entering the market. The court ruled such reverse-payment deals can draw antitrust scrutiny.

Then

The ruling let the FTC continue attacking pay-for-delay settlements and reshaped how brand-generic drug disputes resolve.

Now

It established that financial arrangements keeping cheaper generics out of a market are presumptively suspect under antitrust law.

Why this matters now

Like pay-for-delay, Corteva's program was a financial arrangement that kept cheaper generic products off the market after patent expiry.

Sources

(8)